Glucagon-like Peptide-2

Annu Rev Nutr. 2006:26:391-411. doi: 10.1146/annurev.nutr.26.061505.111223.

Abstract

Multiple peptide hormones produced within the gastrointestinal system aid in the regulation of energy homeostasis and metabolism. Among these is the intestinotrophic peptide glucagon-like peptide-2 (GLP-2), which is released following food intake and plays a significant role in the adaptive regulation of bowel mass and mucosal integrity. The discovery of GLP-2's potent growth-promoting and cytoprotective effects in the gastrointestinal (GI) tract stimulated interest in its use as a therapeutic agent for the treatment of GI diseases involving malabsorption, inflammation, and/or mucosal damage. Current research has focused on determining the physiological mechanisms contributing to the effects of GLP-2 and factors regulating its biological mechanisms of action. This chapter provides an overview of the biology of GLP-2 with a focus on the most recent findings on the role of this peptide hormone in the normal and diseased GI tract.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptation, Physiological
  • Animals
  • Blood Glucose / metabolism
  • Energy Metabolism / physiology*
  • Gastrointestinal Agents / metabolism
  • Gastrointestinal Agents / therapeutic use
  • Gastrointestinal Hormones / metabolism*
  • Glucagon-Like Peptide 2
  • Glucagon-Like Peptides / metabolism*
  • Glucagon-Like Peptides / physiology*
  • Glucagon-Like Peptides / therapeutic use
  • Humans
  • Intestinal Diseases / drug therapy
  • Intestinal Diseases / metabolism
  • Intestinal Mucosa / metabolism
  • Receptors, Glucagon / metabolism

Substances

  • Blood Glucose
  • Gastrointestinal Agents
  • Gastrointestinal Hormones
  • Glucagon-Like Peptide 2
  • Receptors, Glucagon
  • Glucagon-Like Peptides